ImmunityBio
IBRX
IBRX
62 hedge funds and large institutions have $124M invested in ImmunityBio in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
28% less capital invested
Capital invested by funds: $172M → $124M (-$48.4M)
Holders
62
Holding in Top 10
2
Calls
$599K
Puts
$374K
Top Buyers
| 1 | +$1.41M | |
| 2 | +$1.2M | |
| 3 | +$802K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$502K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$357K |
Top Sellers
| 1 | -$9.15M | |
| 2 | -$4.47M | |
| 3 | -$1.51M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$761K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$428K |